Repligen Corporation (RGEN)
NASDAQ: RGEN · Real-Time Price · USD
157.72
+0.80 (0.51%)
Dec 18, 2025, 4:00 PM EST - Market closed
Repligen Employees
Repligen had 1,778 employees as of December 31, 2024. The number of employees decreased by 5 or -0.28% compared to the previous year.
Employees
1,778
Change (1Y)
-5
Growth (1Y)
-0.28%
Revenue / Employee
$398,138
Profits / Employee
$978
Market Cap
8.88B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,778 | -5 | -0.28% |
| Dec 31, 2023 | 1,783 | -242 | -11.95% |
| Dec 31, 2022 | 2,025 | 173 | 9.34% |
| Dec 31, 2021 | 1,852 | 724 | 64.18% |
| Dec 31, 2020 | 1,128 | 367 | 48.23% |
| Dec 31, 2019 | 761 | 213 | 38.87% |
| Dec 31, 2018 | 548 | 72 | 15.13% |
| Dec 31, 2017 | 476 | 240 | 101.69% |
| Dec 31, 2016 | 236 | 68 | 40.48% |
| Dec 31, 2015 | 168 | 32 | 23.53% |
| Dec 31, 2014 | 136 | 20 | 17.24% |
| Dec 31, 2013 | 116 | -4 | -3.33% |
| Dec 31, 2012 | 120 | -17 | -12.41% |
| Dec 31, 2011 | 137 | 69 | 101.47% |
| May 6, 2010 | 68 | -1 | -1.45% |
| May 31, 2009 | 69 | 13 | 23.21% |
| May 27, 2008 | 56 | 11 | 24.44% |
| Jun 30, 2007 | 45 | 2 | 4.65% |
| Jun 6, 2006 | 43 | 6 | 16.22% |
| Jun 7, 2005 | 37 | -3 | -7.50% |
| Jun 7, 2004 | 40 | -4 | -9.09% |
| May 15, 2003 | 44 | 5 | 12.82% |
| May 15, 2002 | 39 | -1 | -2.50% |
| May 15, 2001 | 40 | 13 | 48.15% |
| May 15, 2000 | 27 | 3 | 12.50% |
| May 15, 1999 | 24 | 0 | - |
| May 29, 1998 | 24 | 4 | 20.00% |
| May 15, 1997 | 20 | 5 | 33.33% |
| Jun 14, 1996 | 15 | -89 | -85.58% |
| Mar 31, 1995 | 104 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RGEN News
- 17 hours ago - Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference - GlobeNewsWire
- 2 days ago - Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows - GlobeNewsWire
- 15 days ago - Repligen Corporation (RGEN) Presents at Evercore 8th Annual Healthcare Conference Transcript - Seeking Alpha
- 22 days ago - Repligen Corporation to Present at Evercore Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Repligen Corporation (RGEN) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Repligen Corporation (RGEN) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 weeks ago - Repligen: Rare Growth In The Biopharma Supplies Industry - Seeking Alpha
- 5 weeks ago - Repligen Corporation (RGEN) Presents at Stifel 2025 Healthcare Conference Transcript - Seeking Alpha